Market Summary – Cypherpunk (CYPH)
- 24‑Hour Performance: Cypherpunk fell 10.51 % during the 24‑hour period ending at 10:18 AM Central Europe on Friday, 23 October 2026.
- Current Price: USD 2.98.
- Outstanding Shares: 107.8 million.
- Market Capitalisation: USD 358.9 million.
- Trading Volume (last 24 h): USD 41.2 million.
- Month‑End Performance: Down 17.45 % since the end of the previous month.
- 200‑Day Simple Moving Average: USD 1.22.
- 52‑Week Range: Highest price USD 4.19 (25 September 2026); lowest price USD 0.39 (6 November 2025).
Related Stocks – 24‑Hour Performance
| Symbol | Company | 24‑Hour Change | Current Price | Market Capitalisation |
|---|---|---|---|---|
| TECX | Tectonic Therapeutic | +0.05 % | USD 21.09 | USD 427 million |
| METC | Ramaco | –0.69 % | USD 7.23 | USD 422.3 million |
| SMC | Summit Midstream | +1.69 % | USD 30.40 | USD 422.3 million |
| CIX | Compx | +3.8 % | USD 35.81 | USD 425.6 million |
| KRUS | Kura Sushi Usa | –6.93 % | USD 34.41 | USD 422.3 million |
Additional Information – Ramaco (METC)
- Upcoming Disclosure: Ramaco will release its third‑quarter 2026 financial results on 3 November 2026 after the close of U.S. markets.
- Investor Conference Call: Scheduled for 4:30 p.m. Eastern Time, featuring senior executives including the Chairman and CEO, CFO, and executives responsible for mining, commercial operations, and critical minerals.
- Operations Highlight: Focus on active coal mining complexes in West Virginia and exploration activities in Wyoming, including the Brook Mine project and related carbon research initiatives.
Company Overview – Cypherpunk
Cypherpunk is the trading name for Leap Therapeutics, Inc., a clinical‑stage biopharmaceutical company headquartered in Cambridge, United States. The company develops novel therapeutics for cancer treatment and operates on a global scale. Its shares are listed on the Nasdaq stock exchange. For more detailed information, visit the company website at www.leaptx.com .
